vimarsana.com

Latest Breaking News On - Upadacitinib monotherapy - Page 1 : vimarsana.com

Ryan DeMasi, MD: Upadacitinib Monotherapy Compared with Methotrexate in Rheumatoid Arthritis

Ryan DeMasi, MD, explained despite the patients' shorter disease duration, they exhibited severe symptoms, prompting a more aggressive early intervention approach using treatment with upadacitinib.

Phase 2 Study of Upadacitinib (RINVOQ®) Alone or as a Combination Therapy Meets Primary and Key Secondary Endpoints in Patients with Systemic Lupus Erythematosus

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021

ABBVie today announced the presentation of new data on RINVOQ ® SKYRIZI ® and HUMIRA ® across multiple rheumatic diseases at the American College of Rheumatology's annual meeting to be held virtually Nov. 3-9 . A total of 38 abstracts, including two oral presentations and one plenary session presentation, will be presented from a broad range of studies in rheumatoid arthritis, psoriatic arthritis and ankylosing .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.